| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0005 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0007 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.099 | 0.001 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.09 | 0.002 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |